Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-20

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study will describe lung ultrasound (LUS) findings over time in hospitalized patients with moderate to severe Covid-19 lung disease. Our primary aim is to investigate if lung ultrasound can identify and/or predict patients requiring mechanical ventilation. Another aim is to describe LUS findings associated with clinical findings and patient condition.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19

NCT04327674

COVID-19

COMPLETED

CORonavirus (COVID-19) Diagnostic Lung UltraSound Study

NCT04351802

COVID-19

COMPLETED

Lung Ultrasound for COVID-19 Initial Triage and Monitoring

NCT04474236

COVID-19 Acute Respiratory Failure Triage +2 more

COMPLETED

Simple, Safe, Same: Lung Ultrasound for COVID-19

NCT04322487

Coronavirus Epidemic Disease Pneumonia, Viral

COMPLETED

Predicting Outcomes for Covid-19 Using Sonography

NCT04384055

COVID-19 Pneumonia, Viral

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study patients with moderate to severe Covid-19 infection will be screened with lung ultrasound daily. Lung ultrasound will be assessed by LUS-score for acute respiratory distress syndrome (ARDS) (0-36 points, Bouhemad 2015). Findings of B-line artifacts and consolidations will be noted. In addition to LUS, clinical parameters from physical examination and laboratory tests will be collected. Participants wil be followed until either admission to intensive care unit (ICU) for mechanical ventilation or until clinical improvement. A group of patients with mild Covid-19 infection will be recruited and screened once as reference.

Apart from assessment with LUS, patients are managed according to routine care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Corona Virus Infection Virus Diseases Coronaviridae Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Covid-19 confirmed by positive polymerase chain reaction (PCR)
* oxygen by mask or nasal prongs ≥ 4 l/min or high flow nasal cannula (HFNC) with fraction of inspired oxygen (FiO2) ≥ 30%
* age between 18-80 years
* informed consent

Exclusion Criteria

* patients subject to treatment-limitation "no ICU"
* history of heart failure
* history of lung disease e.g.: pneumonectomy, pulmonary fibrosis or other interstitial lung disease, pleurodesis
* history of kidney failure requiring dialysis
* any reason making lung ultrasound or daily follow up impossible
* opposition to participation in the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No